Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
暂无分享,去创建一个
Gregory S. Nelson | David A. Kass | Barry J. Fetics | Ronald D. Berger | Joshua M. Hare | D. Kass | B. Fetics | J. Spinelli | G. S. Nelson | M. Talbot | R. Berger | J. Hare | Maurice Talbot | Julio C. Spinelli
[1] Andrew P. Kramer,et al. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. , 2000, Circulation.
[2] D. Sawyer,et al. Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited. , 2000, Circulation research.
[3] J. Willerson. Circulation's first 50 years: January 1950 to January 2000. , 2000, Circulation.
[4] D. Kass,et al. Mechanical dyssynchrony in dilated cardiomyopathy with intraventricular conduction delay as depicted by 3D tagged magnetic resonance imaging. , 2000, Circulation.
[5] C. H. Chen,et al. Comparison of ventricular pressure relaxation assessments in human heart failure: quantitative influence on load and drug sensitivity analysis. , 1999, Journal of the American College of Cardiology.
[6] J. Hoerter,et al. Subcellular creatine kinase alterations. Implications in heart failure. , 1999, Circulation research.
[7] R. Califf,et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). , 1999, American heart journal.
[8] AngeloAuricchio,et al. Effect of Pacing Chamber and Atrioventricular Delay on Acute Systolic Function of Paced Patients With Congestive Heart Failure , 1999 .
[9] F W Prinzen,et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. , 1999, Journal of the American College of Cardiology.
[10] C. H. Chen,et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. , 1999, Circulation.
[11] E. Daoud,et al. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. , 1999, The American journal of cardiology.
[12] E. McVeigh,et al. Mapping propagation of mechanical activation in the paced heart with MRI tagging. , 1999, American journal of physiology. Heart and circulatory physiology.
[13] L. La Vecchia,et al. Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy. , 1999, The American journal of cardiology.
[14] H Le Breton,et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. , 1998, Journal of the American College of Cardiology.
[15] J. Ingwall,et al. Nitric oxide, myocardial oxygen consumption, and ATP synthesis. , 1998, Circulation research.
[16] F. Recchia,et al. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.
[17] P. Poole‐Wilson,et al. Successes and failures of current treatment of heart failure , 1998, The Lancet.
[18] W. Colucci,et al. New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress , 1998, The Lancet.
[19] B. Massie. 15 years of heart-failure trials: what have we learned? , 1998, The Lancet.
[20] J. Blanc,et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.
[21] C. Brohet,et al. Dispersion of ventricular repolarization in dilated cardiomyopathy. , 1997, European heart journal.
[22] A. Katz. Is the failing heart an energy-starved organ? , 1996, Journal of cardiac failure.
[23] A. Lazarus,et al. Multisite Pacing for End‐Stage Heart Failure: Early Experience , 1996, Pacing and clinical electrophysiology : PACE.
[24] D. Burkhoff,et al. Effects of levosimendan on myocardial contractility and oxygen consumption. , 1996, The Journal of pharmacology and experimental therapeutics.
[25] M. Packer. New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms , 1996, Journal of internal medicine.
[26] D. Gibson,et al. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. , 1996, International journal of cardiology.
[27] H. Suga,et al. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle. Better alternative to exponential time constant. , 1995, Circulation.
[28] P. Grayburn,et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. , 1994, Journal of the American College of Cardiology.
[29] W. Remme,et al. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. , 1994, Journal of cardiovascular pharmacology.
[30] N. Alpert,et al. Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabain. , 1994, Cardiovascular research.
[31] M. Schwaiger,et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.
[32] P. Wilmshurst. Why inotropes continue to disappoint in heart failure. , 1993, British heart journal.
[33] C. Richard,et al. Cardiac index vs oxygen-derived parameters for rational use of dobutamine in patients with congestive heart failure. , 1993, Chest.
[34] G. Critelli,et al. Resting and ambulatory ECG predictors of mode of death in dilated cardiomyopathy. , 1992, Journal of electrocardiology.
[35] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.
[36] P. Grayburn,et al. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. , 1990, Circulation.
[37] R D Fish,et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. , 1990, Circulation.
[38] H Suga,et al. Ventricular energetics. , 1990, Physiological reviews.
[39] T. Meinertz,et al. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. , 1989, Circulation.
[40] T. Meinertz,et al. Influence of Enoximone on Myocardial Energetics in Patients with Idiopathic Dilated Cardiomyopathy: Comparison with Nitroprusside , 1989, Journal of cardiovascular pharmacology.
[41] H. F. Marlow. The Efficacy of Xamoterol in Heart Failure of Ischemic Origin , 1989, Journal of cardiovascular pharmacology.
[42] R. Huth,et al. Acute Hemodynamic Response to Intravenous Enoximone: An Animal Study and Preliminary Report in Infants After Cardiac Surgery , 1989, Journal of cardiovascular pharmacology.
[43] K. Sagawa,et al. Influence of pacing site on canine left ventricular contraction. , 1986, The American journal of physiology.
[44] E. Braunwald,et al. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. , 1986, Circulation.
[45] R. O'rourke,et al. Effect of alteration of left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. , 1985, Circulation research.
[46] B. Pitt,et al. Coronary Hemodynamic Effects of Increasing Ventricular Rate in the Unanesthetized Dog , 1968, Circulation research.